Methner U, Barrow P A, Gregorova D, Rychlik I
Federal Research Centre for Virus Diseases of Animals, Bundesforschungsanstalt für Viruskrankheiten der Tiere (BFAV) Institute for Bacterial Infections and Zoonoses, Naumburger Str. 96a, D-07743 Jena, Germany.
Vet Microbiol. 2004 Jan 14;98(1):37-43. doi: 10.1016/j.vetmic.2003.10.019.
Administration of live Salmonella strains to day-old chicks provides profound protection against superinfection with a related strain within a matter of hours by a colonisation-inhibition mechanism, which is primarily a bacterial physiological process. Although currently available, commercial, live attenuated Salmonella vaccines induce protection by adaptive immunity, none of them is able to induce protection against Salmonella organisms by colonisation-inhibition and, therefore, they are unable to protect newly-hatched birds immediately after oral vaccination. In this study, mutants of Salmonella Typhimurium and Enteritidis with deletions in phoP and rpoS, either alone or in combination with ompC, were characterised and tested for their level of attenuation and their ability to inhibit the intestinal colonisation of the isogenic parent strains in chickens. Mutants with deletions only in rpoS demonstrated an unaffected potential to inhibit the intestinal colonisation of the challenge strain but were still fully virulent for the chickens. Mutants with deletions in phoP, either alone or in combination with rpoS, resulted in a high level of attenuation, unimpaired ability to colonise the gut and a nearly unaffected potential to inhibit the challenge strain from caecal colonisation. Mutants with an additional deletion in ompC revealed a reduced capacity of intestinal colonisation-inhibition when compared to the control strains and both the single rpoS and the phoP deletion mutants. Mutations in phoP- or phoP-regulated genes may therefore be used for the development of live attenuated Salmonella vaccines possessing these novel characteristics.
给一日龄雏鸡接种活沙门氏菌菌株,可在数小时内通过定殖抑制机制对相关菌株的重复感染提供深度保护,而定殖抑制机制主要是一个细菌生理过程。尽管目前有商业化的减毒活沙门氏菌疫苗通过适应性免疫诱导保护作用,但它们均无法通过定殖抑制诱导针对沙门氏菌的保护作用,因此,它们无法在口服疫苗接种后立即保护新孵化的雏鸡。在本研究中,对鼠伤寒沙门氏菌和肠炎沙门氏菌的phoP和rpoS基因单独或与ompC基因组合缺失的突变体进行了特性鉴定,并测试了它们的减毒水平以及抑制鸡体内同源亲本菌株肠道定殖的能力。仅rpoS基因缺失的突变体抑制攻击菌株肠道定殖的潜力未受影响,但对雏鸡仍具有完全毒性。phoP基因单独或与rpoS基因组合缺失的突变体导致高度减毒,定殖肠道的能力未受损,抑制攻击菌株盲肠定殖的潜力几乎未受影响。与对照菌株以及单个rpoS和phoP缺失突变体相比,ompC基因额外缺失的突变体显示出肠道定殖抑制能力降低。因此,phoP或受phoP调控基因中的突变可用于开发具有这些新特性的减毒活沙门氏菌疫苗。